Skip to Main Content
Skip Nav Destination

Signal transducer and activator of transcription 3 (STAT3) protein, a member of the STAT family of cytosolic signalling proteins, controls the transcription of genes that facilitate and promote several known hallmarks of cancer, including uncontrolled cell proliferation and immortality. Significant efforts have been made to inhibit the action of this oncogenic protein with small molecules, peptides, peptidomimetics, oligonucleotides and organometallic agents. This chapter will describe the progress toward a nanomolar binding, STAT3-selective drug with pharmacological properties suitable for clinical trials and ultimately application in clinical settings against human diseases.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal